Ultime notizie per BNY Mellon Innovators ETF (NASDAQ:BKIV)

Technology

Healthcare

Consumer Cyclical

Communication Services

Consumer Defensive

Real Estate

Energy

To pursue its goal, the fund normally invests principally in equity securities of U.S. innovation-driven companies. The fund's sub-adviser, Newton Investment Management North America, LLC (NIMNA), an affiliate of the Adviser, considers innovation-driven companies to be (i) leading edge companies that, through their intellectual property, provide ground-breaking or innovative products and services that can be disruptive and transformative to existing business models and practices and (ii) business enterprises that are positively impacted by the transformation of their business models and practices through the use of such products or services.

Nvidia Corp.

Alphabet Inc., Class C

Insmed Inc

Costar Group Inc.

Repligen Inc.

Netflix Inc.

Inspire Med Sys Inc

Align Technology Inc.

Celsius Holdings Inc Common Stock USD 0.001

Freshpet Inc.

Klaviyo Inc

Confluent, Inc.

Irhythm Technologies Inc.

Shopify Inc Class A

BNY Mellon Innovators ETF

B of A Securities analyst Ebrahim Poonawala maintains First Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) with a Buy and raises the price target from $23 to $24.

News

Price Target

Analyst Ratings

B of A Securities Maintains Buy on First Horizon, Raises Price Target to $24

LLY: 14% &#x7C; <a href="https://www.benzinga.com/node/44859707">Eli Lilly shares are trading higher after the company announced topline Phase 3 results from its ACHIEVE-1 trial, which showed orforglipron demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines.</a>
&nbsp;
UNH: -20% &#x7C; <a href="https://www.benzinga.com/node/44859620">UnitedHealth shares are trading lower after the company reported worse-than-expected Q1 results and cut its FY25 adjusted EPS guidance below estimates.</a>
&nbsp;
HTZ: 120% &#x7C; <a href="https://www.benzinga.com/node/44859590">Hertz Global shares are trading higher after Pershing Square Capital Management disclosed a stake via a 13F. CNBC reported that Pershing Square's stake is 19.8%, through shares &amp; swaps.</a>

Movers

Trading Ideas

Market-Moving News for April 17th

Longbow Research analyst David Macgregor initiates coverage on Twin Disc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWIN#NASDAQ">TWIN</a>) with a Buy rating and announces Price Target of $12.

Initiation

TWIN

Longbow Research Initiates Coverage On Twin Disc with Buy Rating, Announces Price Target of $12

B of A Securities analyst Tim Anderson maintains Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) with a Underperform and lowers the price target from $575 to $547.

REGN

B of A Securities Maintains Underperform on Regeneron Pharmaceuticals, Lowers Price Target to $547

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
<h3 class="wp-block-heading">Annaly Capital Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>)</h3>
<ul>
<li>Dividend Yield: 15.88%</li>
<li>JP Morgan analyst Richard Shane maintained an Overweight rating and cut the price target from $21 to $19 on April 16, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained an Outperform rating and cut the price target from $21 to $20.15 on April 8, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: Annaly Capital Management will release its financial results for the quarter ended March 31, after the closing bell on Wednesday, April 30.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417">latest NLY news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="905" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070257/image-1-6.png" alt="" class="wp-image-876303" style="width:553px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070257/image-1-6.png 905w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070257/image-1-6-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070257/image-1-6-768x713.png 768w" sizes="(max-width: 905px) 100vw, 905px" /></a></figure>
<h3 class="wp-block-heading">PennantPark Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNNT#NYSE">PNNT</a>)</h3>
<ul>
<li>Dividend Yield: 15.48%</li>
<li>Ladenburg Thalmann analyst Mickey Schleien downgraded the stock from Buy to Neutral on Nov. 27, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Compass Point analyst Casey Alexander upgraded the stock from Sell to Neutral with a price target of $6 on Sept. 9, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: PennantPark Investment will report results for the second fiscal quarter on Monday, May 12, after the close of the financial markets.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417">PNNT news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="898" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070334/image-1-7.png" alt="" class="wp-image-876304" style="width:556px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070334/image-1-7.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070334/image-1-7-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070334/image-1-7-768x707.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure>
<h3 class="wp-block-heading">New York Mortgage Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NASDAQ">NYMT</a>)</h3>
<ul>
<li>Dividend Yield: 15.01%</li>
<li>UBS analyst Douglas Harter maintained a Neutral rating and cut the price target from $7.5 to $6 on May 8, 2024. This analyst has an accuracy rate of 68%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained a Market Perform rating and cut the price target from $8.5 to $7 on May 3, 2024. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: New York Mortgage Trust will report financial results for the three months ended March 31, 2025 after the closing bell on April 30.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest NYMT <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="920" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070418/image-17.png" alt="" class="wp-image-876305" style="width:505px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070418/image-17.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070418/image-17-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17070418/image-17-768x707.png 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44857276/netflix-unitedhealth-group-and-3-stocks-to-watch-heading-into-thursday">Netflix, UnitedHealth Group And 3 Stocks To Watch Heading Into Thursday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Pre-Market Outlook

Markets

NYMT

PNNT

Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks With Over 15% Dividend Yields

B of A Securities analyst Jason Kupferberg maintains Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) with a Buy and lowers the price target from $94 to $80.

B of A Securities Maintains Buy on Block, Lowers Price Target to $80

Keybanc analyst Noah Zatzkin upgrades YETI Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) from Underweight to Sector Weight.

Upgrades

YETI

Keybanc Upgrades YETI Holdings to Sector Weight

Guidance

American Express Sees FY25 EPS $15-$15.50 Vs $17.51 Estimate

Guidance for FY26: &nbsp;• Revenue growth of 0%-3% in constant currency • Operating margin of 20%-22%&nbsp;

INFY

Infosys Expects FY26 Revenue Growth Of 0.0%-3.0% In Constant Currency, Reiterated Operating Margin of 20%-22%

Buybacks

AVIR

Atea Pharmaceuticals Board authorizes Repurchase Of Up To $25M Of Common Stock

A federal labor agency has found itself at the center of a cybersecurity controversy after a whistleblower alleged DOGE workers set off a major data breach.
The allegations, shared with Congress and made public by Whistleblower Aid, indicate unauthorized access and possible data exfiltration from the National Labor Relations Board (NLRB).
What Happened: Daniel Berulis, an IT staffer at the NLRB, said in an affidavit that the DOGE Service team was given wide-ranging access to internal systems.
He reported unusual activity beginning in March, such as tampered logging protocols and the removal of roughly 10 gigabytes of sensitive data. NPR <a href="https://www.npr.org/2025/04/15/nx-s1-5355896/doge-nlrb-elon-musk-spacex-security">reported</a> that the files seemingly included private affidavits, union-related information, and proprietary business documents.
See Also: <a href="https://www.benzinga.com/25/04/44857730/elon-musks-team-reportedly-installs-satellite-equipment-at-key-federal-agency-raising-oversight-questions">Elon Musk&#8217;s Team Installs Starlink Satellite Equipment At Key Federal Agency: Report</a>
Why It Matters: The NLRB deals with confidential labor complaints and union organizing data. Breaches like these could jeopardize investigations and expose sensitive corporate and worker information. Berulis also made note of attempted logins from a Russian IP address using valid credentials, raising further red flags about security conditions.
Berulis said efforts to report the incident to federal cybersecurity authorities were resisted by agency leadership, and that he had received a threatening message at his home.
Following the disclosure, NPR <a href="https://www.npr.org/2025/04/16/nx-s1-5366851/doge-nlrb-whistleblower-musk-data">reported</a> that DOGE allocated two staffers to work part-time at the NLRB.
DOGE has been previously linked with privacy and security concerns across other federal agencies, such as its attempts to access<a href="https://www.benzinga.com/personal-finance/25/04/44697671/trump-administrations-push-to-access-social-security-data-faces-major-setback-as-court-dismisses-appeal"> data from the Social Security Administration</a>, <a href="https://www.benzinga.com/news/25/02/43768756/privacy-concerns-emerge-as-elon-musks-doge-team-seeks-access-to-taxpayer-data">taxpayer data</a>, and its reported <a href="https://www.benzinga.com/politics/25/04/44683851/elon-musks-secretive-doge-team-using-ai-and-disappearing-messages-to-monitor-federal-workers-for-anti-trump-sentiment-bypassing-records-laws-and-locking-out-agencies-report">tracking of employee communications using AI tools.</a>
These latest developments have coincided with news that Elon Musk has reportedly slashed DOGE's projected federal budget savings target from <a href="https://www.benzinga.com/25/04/44759007/did-elon-musk-just-lower-doges-1-trillion-savings-target-to-150-billion-in-a-second-revision-since-jan">$1 trillion to $150 billion</a> for 2026, making this the second revision amid increasing scrutiny over inflated savings claims and economic risks.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/04/44835225/netflixs-black-mirror-returns-with-grim-warning-about-life-trapped-behind-endless-paywalls">Netflix&#8217;s &#8216;Black Mirror&#8217; Returns With Grim Warning About Life Trapped Behind Endless Paywalls</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

Tech

General

Whistleblower Says DOGE May Have Caused Major Cybersecurity Breach At US Labor Agency

FDA Accepts Regeneron's EYLEA HD Injection 8 mg sBLA For Priority Review For Treatment Of Macular Edema Following Retinal Vein Occlusion And For Monthly Dosing In Approved Indications

Cannabis

Stock Split

TLRY

Tilray Brands To Vote For Implementation Of Reverse Stock Split At A Ratio Ranging From 1-to-10 To 1-to-20

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025
GS-6791/NX-0479 has potential clinical applications across multiple blockbuster markets in inflammation, in both rheumatology and dermatology, including rheumatoid arthritis and atopic dermatitis
Nurix to receive a $5 million milestone payment from Gilead for FDA clearance of the IND, bringing the total amount received under the 2019 collaboration agreement to $135 million
Nurix is eligible for an additional $420 million in development, regulatory and commercial milestones associated with the IRAK4 degrader program as well as potential future royalties and retains an option to co-develop and co-detail in the United States with the parties splitting U.S. profits and losses
SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, announced today that the U.S. Food and Drug Administration (FDA) has cleared the IND for the IRAK4 degrader GS-6791/NX-0479, enabling the initiation of a Phase 1 trial, which is anticipated to begin in Q2 2025.

NRIX

Nurix Therapeutics Says FDA Clears IND for IRAK4 Degrader GS-6791/NX-0479, Enabling Initiation Of Phase 1 trial, Which Is Expected To Begin in Q2 2025

Infosys Q4 EPS $0.20 Beats $0.19 Estimate, Sales $4.73B Miss $4.90B Estimate

American Express Sees 2025 Revenue Growth 8%-10%

B of A Securities analyst Ken Hoexter maintains CSX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) with a Neutral and lowers the price target from $33 to $30.

B of A Securities Maintains Neutral on CSX, Lowers Price Target to $30

GOLDEN, Colo. and SOLANA BEACH, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a <a href="https://www.globenewswire.com/Tracker?data=1oRLIVCu-4-cKdDAAkK12qdW1rELIENT4C3ZdqlN7ki0oN-oVm6RjqqdY9QQMjIqmQrV7G_5KPBPGqNmm53GMwChRFaFHYDCAq0E33X-hMQ=">Safe Harbor Financial</a> (Safe Harbor) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>), a fintech leader in facilitating financial services and credit facilities to the regulated cannabis industry, announced a strategic partnership with <a href="https://www.globenewswire.com/Tracker?data=MfJ5jG3z1zLcxKHGnnrtJurjH3giFpBqk26zE8SnvtyBmXMbXG0uFjxz4QHJMQNYc6nCb7plPNkzpmeGyNjENA==">FundCanna</a>, the leading provider of flexible capital solutions for cannabis operators. Through a mutual referral agreement, the two companies will collaborate to bring accessible, transparent funding options and compliant banking services to cannabis-related businesses (CRBs) across the United States.
This partnership enables FundCanna to introduce clients to Safe Harbor; and Safe Harbor to introduce qualified clients to FundCanna for working capital, equipment financing and other credit-based solutions. Under the agreement, all FundCanna-approved clients referred by Safe Harbor will be onboarded to deposit loan proceeds directly into Safe Harbor-managed bank accounts, ensuring full regulatory compliance and transparency.

SHF Holdings, Inc. - Class A Common Stock

SHFS

SHF Holdings Announces Strategic Partnership With FundCanna  To Expand Access To Capital For Cannabis Operators

American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) reported quarterly earnings of $3.64 per share which beat the analyst consensus estimate of $3.47 by 4.9 percent. This is a 9.31 percent increase over earnings of $3.33 per share from the same period last year. The company reported quarterly sales of $16.97 billion which beat the analyst consensus estimate of $16.94 billion by 0.18 percent. This is a 7.38 percent increase over sales of $15.80 billion the same period last year.

Earnings Beats

American Express Q1 2025 GAAP EPS $3.64 Beats $3.47 Estimate, Sales $16.97B Beat $16.94B Estimate

B of A Securities analyst Joshua Shanker maintains Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) with a Neutral and raises the price target from $289 to $297.

B of A Securities Maintains Neutral on Progressive, Raises Price Target to $297

Comments

BNY Mellon Innovators ETF

Notizie

Ultime notizie per BNY Mellon Innovators ETF (NASDAQ:BKIV)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO